Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desmoteplase in Acute Ischemic Stroke (DIAS-3)
NCT00790920Phase 3Completed
- Sponsor
- Lundbeck
- Start
- Dec 2008
- Primary completion
- Jul 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 17
01
Overview
A Phase 3 trial of desmoteplase in ischemic stroke, sponsored by Lundbeck. Started Dec 2008; status: completed.
02
Drugs
desmoteplase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT00790920.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00790920.